- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 305/14 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 305/14
Total number of patents in this class: 306
10-year publication summary
14
|
17
|
16
|
12
|
16
|
8
|
8
|
13
|
13
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Indena S.p.A. | 626 |
12 |
Nektar Therapeutics | 438 |
7 |
Aventis Pharma S.A. | 54 |
6 |
Fresenius Kabi Oncology Limited | 66 |
6 |
Novomer, Inc. | 212 |
6 |
Alethia Biotherapeutics Inc. | 21 |
5 |
Shenyang Pharmaceutical University | 108 |
5 |
Starpharma Pty Limited | 69 |
5 |
The University of British Columbia | 1495 |
5 |
Shanghai Parling Pharma-Tech. Co., Ltd. | 5 |
5 |
6570763 Canada Inc. | 4 |
4 |
Hanmi Pharm. Co., Ltd. | 571 |
4 |
The Research Foundation for The State University of New York | 1621 |
4 |
Shilpa Medicare Limited | 110 |
4 |
Tapestry Pharmaceuticals, Inc. | 26 |
4 |
AstraZeneca AB | 2892 |
3 |
Life Technologies Corporation | 3306 |
3 |
Dalian Institute of Chemical Physics, Chinese Academy of Sciences | 671 |
3 |
Inner Mongolia Puyin Pharmaceutical Co., Ltd | 10 |
3 |
Institute of Materia Medica, Chinese Academy of Medical Sciences | 178 |
3 |
Other owners | 209 |